<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a 42-year-old woman who developed superior sagittal and left transverse sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> associated with prolonged <z:chebi fb="0" ids="16586">epsilon-aminocaproic acid</z:chebi> therapy for <z:hpo ids='HP_0000132'>menorrhagia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This <z:chebi fb="0" ids="48675">antifibrinolytic agent</z:chebi> has been used in women with <z:hpo ids='HP_0000132'>menorrhagia</z:hpo> to promote clotting and reduce blood loss </plain></SENT>
<SENT sid="2" pm="."><plain>Although increased risk of <z:hpo ids='HP_0001907'>thromboembolic disease</z:hpo> has been reported during treatment with <z:chebi fb="0" ids="16586">epsilon-aminocaproic acid</z:chebi>, cerebral sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> has not been previously described </plain></SENT>
<SENT sid="3" pm="."><plain>Careful use of <z:chebi fb="0" ids="16586">epsilon-aminocaproic acid</z:chebi> therapy is recommended </plain></SENT>
</text></document>